Skip to main content
Log in

Hepatic Lipase Gene −514C/T Polymorphism in the Guangxi Hei Yi Zhuang and Han Populations

  • Original Article
  • Published:
Lipids

Abstract

Hei Yi Zhuang is an isolated subgroup of the Zhuang minority in China. This study was designed to compare the difference in the hepatic lipase gene (LIPC) −514C/T polymorphism and its association with lipid profiles between the Guangxi Hei Yi Zhuang and Han populations. Genotyping of the LIPC −514C/T was performed in 873 subjects of Hei Yi Zhuang and 867 participants of Han Chinese. The frequency of −514T allele was 43.47% in Hei Yi Zhuang, and 36.10% in Han (< 0.001). The frequencies of CC, CT and TT genotypes were 30.01, 53.04 and 16.95% in Hei Yi Zhuang, and 40.95, 45.91 and 13.14% in Han (< 0.001); respectively. Serum high-density lipoprotein cholesterol (HDL-C) and apolipoprotein B levels in both ethnic groups were higher in LIPC −514T carriers than in C carriers. In addition, serum triglyceride levels in Han were higher in TT genotype individuals than in CC genotype subjects (< 0.05). Serum HDL-C levels were positively correlated with age, alcohol consumption and LIPC −514C/T genotypes, and negatively associated with hypertension and cigarette smoking in Hei Yi Zhuang (< 0.05–0.01), whereas HDL-C levels were positively correlated with age, alcohol consumption and LIPC −514C/T genotypes, and negatively associated with body mass index and cigarette smoking in Han (< 0.05–0.001). The differences in serum HDL-C levels between the two ethnic groups might partially attribute to the differences in the LIPC −514C/T polymorphism.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

ANCOVA:

Analysis of covariance

Apo:

Apolipoprotein

BMI:

Body mass index

CHD:

Coronary heart disease

DNA:

Deoxyribonucleic acid

HDL-C:

High-density lipoprotein cholesterol

HL:

Hepatic lipase

LDL-C:

Low-density lipoprotein cholesterol

LIPC :

Hepatic lipase gene

PCR:

Polymerase chain reaction

SNP:

Single nucleotide polymorphisms

TC:

Total cholesterol

TG:

Triglyceride

References

  1. Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD, Castelli WP, Knoke JD, Jacobs DR Jr, Bangdiwala S, Tyroler HA (1989) High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 79:8–15

    PubMed  CAS  Google Scholar 

  2. Heller DA, de Faire U, Pedersen NL, Dahlén G, McClearn GE (1993) Genetic and environmental influences on serum lipid levels in twins. N Engl J Med 328:1150–1156

    Article  PubMed  CAS  Google Scholar 

  3. Steinmetz J, Boerwinkle E, Gueguen R, Visvikis S, Henny J, Siest G (1992) Multivariate genetic analysis of high density lipoprotein particles. Atherosclerosis 92:219–227

    Article  PubMed  CAS  Google Scholar 

  4. Cohen JC, Wang Z, Grundy SM, Stoesz MR, Guerra R (1994) Variation at the hepatic lipase and apolipoprotein AI/CIII/AIV loci is a major cause of genetically determined variation in plasma HDL cholesterol levels. J Clin Invest 94:2377–2384

    Article  PubMed  CAS  Google Scholar 

  5. Jansen H, Verhoeven AJ, Weeks L, Kastelein JJ, Halley DJ, van den Ouweland A, Jukema JW, Seidell JC, Birkenhager JC (1997) A common C-to-T substitution at position 2480 of the hepatic lipase promoter associated with a lowered lipase activity in coronary artery disease patients. Arterioscler Thromb Vasc Biol 17:2837–2842

    PubMed  CAS  Google Scholar 

  6. Guerra R, Wang J, Grundy SM, Cohen JC (1997) A hepatic lipase (LIPC) allele associated with high plasma concentrations of high density lipoprotein cholesterol. Proc Natl Acad Sci USA 94:4532–4537

    Article  PubMed  CAS  Google Scholar 

  7. Santamarina-Fojo S, Haudenschild C, Amar M (1998) The role of hepatic lipase in lipoprotein metabolism and atherosclerosis. Curr Opin Lipidol 9:211–219

    Article  PubMed  CAS  Google Scholar 

  8. Perret B, Mabile L, Martinez L, Tercé F, Barbaras R, Collet X (2002) Hepatic lipase: structure/function relationship, synthesis, and regulation. J Lipid Res 43:1163–1169

    PubMed  CAS  Google Scholar 

  9. Deeb SS, Zambon A, Carr MC, Ayyobi AF, Brunzell JD (2003) Hepatic lipase and dyslipidemia: interactions among genetic variants, obesity, gender, and diet. J Lipid Res 44:1279–1286

    Article  PubMed  CAS  Google Scholar 

  10. Kuusi T, Saarinen P, Nikkilä EA (1980) Evidence for the role of hepatic endothelial lipase in the metabolism of plasma high density lipoprotein2 in man. Atherosclerosis 36:589–593

    Article  PubMed  CAS  Google Scholar 

  11. Salonen JT, Salonen R, Seppänen K, Rauramaa R, Tuomilehto J (1991) HDL, HDL2, and HDL3 subfractions, and the risk of acute myocardial infarction. A prospective population study in eastern Finnish men. Circulation 84:129–139

    PubMed  CAS  Google Scholar 

  12. Lamarche B, Moorjani S, Cantin B, Dagenais GR, Lupien PJ, Després JP (1997) Associations of HDL2 and HDL3 subfractions with ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study. Arterioscler Thromb Vasc Biol 17:1098–1105

    PubMed  CAS  Google Scholar 

  13. Bensadoun A, Berryman DE (1996) Genetics and molecular biology of hepatic lipase. Curr Opin Lipidol 7:77–81

    PubMed  CAS  Google Scholar 

  14. Cohen JC, Vega GL, Grundy SM (1999) Hepatic lipase: new insights from genetic and metabolic studies. Curr Opin Lipidol 10:259–267

    Article  PubMed  CAS  Google Scholar 

  15. Couture P, Otvos JD, Cupples LA, Lahoz C, Wilson PW, Schaefer EJ, Ordovas JM (2000) Association of the C-514T polymorphism in the hepatic lipase gene with variations in lipoprotein subclass profiles: the Framingham offspring study. Arterioscler Thromb Vasc Biol 20:815–822

    PubMed  CAS  Google Scholar 

  16. vant Hooft FM, Lundahl B, Ragogna F, Karpe F, Olivecrona G, Hamsten A (2000) Functional characterization of 4 polymorphisms in promoter region of hepatic lipase gene. Arterioscler Thromb Vasc Biol 20:1335–1339

    Google Scholar 

  17. Murtomaki S, Tahvanainen E, Antikainen M, Tiret L, Nicaud V, Jansen H, Ehnholm C (1997) Hepatic lipase gene polymorphisms influence plasma HDL levels. Results from Finnish EARS participants. European atherosclerosis research study. Arterioscler Thromb Vasc Biol 17:1879–1884

    PubMed  CAS  Google Scholar 

  18. Zambon A, Deeb SS, Hokanson JE, Brown BG, Brunzell JD (1998) Common variants in the promoter of the hepatic lipase gene are associated with lower levels of hepatic lipase activity, buoyant LDL, and higher HDL2 cholesterol. Arterioscler Thromb Vasc Biol 18:1723–1729

    PubMed  CAS  Google Scholar 

  19. Vega GL, Clark LT, Tang A, Marcovina S, Grundy SM, Cohen JC (1998) Hepatic lipase activity is lower in African American men than in white American men: effects of 5′ flanking polymorphism in the hepatic lipase gene (LIPC). J Lipid Res 39:228–232

    PubMed  CAS  Google Scholar 

  20. Shohet RV, Vega GL, Bersot TP, Mahley RW, Grundy SM, Guerra R, Cohen JC (2002) Sources of variability in genetic association studies: insights from the analysis of hepatic lipase (LIPC). Hum Mutat 19:536–542

    Article  PubMed  CAS  Google Scholar 

  21. Yin R, Chen Y, Pan S, He F, Liu T, Yang D, Wu J, Yao L, Lin W, Li R, Huang J (2006) Effects of demographic, dietary and other lifestyle factors on the prevalence of hyperlipidemia in Guangxi Hei Yi Zhuang and Han populations. Eur J Cardiovasc Prev Rehabil 13:977–984

    Article  Google Scholar 

  22. Yin R, Li R, Lin W, Yang D, Pan S (2006) Effect of the MTP −493 G/T polymorphism on the lipid profiles of the Guangxi Hei Yi Zhuang and Han populations. Eur J Lipid Sci Technol 108:561–568

    Article  CAS  Google Scholar 

  23. Yin R, Yao L, Chen Y, Yang D, Lin W, Li M, He F, Wu J, Ye G, Nong Z (2006) Prevalence, awareness, treatment, control and risk factors of hypertension in the Guangxi Hei Yi Zhuang and Han populations. Hypertens Res 29:423–432

    Article  Google Scholar 

  24. Cooperative Meta-analysis Group of China Obesity Task Force (2002) Predictive values of body mass index and waist circumference to risk factors of related diseases in Chinese adult population. Zhonghua Liu Xing Bing Xue Za Zhi 23:5–10

    Google Scholar 

  25. Tai ES, Corella D, Deurenberg-Yap M, Cutter J, Chew SK, Tan CE, Ordovas JM, Singapore National Health Survey (2003) Dietary fat interacts with the −514C>T polymorphism in the hepatic lipase gene promoter on plasma lipid profiles in a multiethnic Asian population: the 1998 Singapore National Health Survey. J Nutr 133:3399–3408

    PubMed  CAS  Google Scholar 

  26. Ko YL, Hsu LA, Hsu KH, Ko YH, Lee YS (2004) The interactive effects of hepatic lipase gene promoter polymorphisms with sex and obesity on high-density-lipoprotein cholesterol levels in Taiwanese-Chinese. Atherosclerosis 172:135–142

    Article  PubMed  CAS  Google Scholar 

  27. Tan KC, Shiu SW, Chu BY (2001) Effects of gender, hepatic lipase gene polymorphism and type 2 diabetes mellitus on hepatic lipase activity in Chinese. Atherosclerosis 157:233–239

    Article  PubMed  CAS  Google Scholar 

  28. Nie L, Niu S, Vega GL, Clark LT, Tang A, Grundy SM, Cohen JC (1998) Three polymorphisms associated with low hepatic lipase activity are common in African Americans. J Lipid Res 39:1900–1903

    PubMed  CAS  Google Scholar 

  29. Tahvanainen E, Syvanne M, Frick MH, Murtomaki-Repo S, Antikainen M, Kesaniemi YA, Kauma H, Pasternak A, Taskinen MR, Ehnholm C (1998) Association of variation in hepatic lipase activity with promoter variation in the hepatic lipase gene. The LOCAT study investigators. J Clin Invest 101:956–960

    Article  PubMed  CAS  Google Scholar 

  30. Hegele RA, Harris SB, Brunt JH, Young TK, Hanley AJ, Zinman B, Connelly PW (1999) Absence of association between genetic variation in the LIPC gene promoter and plasma lipoproteins in three Canadian populations. Atherosclerosis 146:153–160

    Article  PubMed  CAS  Google Scholar 

  31. Shohet RV, Vega GL, Anwar A, Cigarroa JE, Grundy SM, Cohen JC (1999) Hepatic lipase (LIPC) promoter polymorphism in men with coronary artery disease. Allele frequency and effects on hepatic lipase activity and plasma HDL-C concentrations. Arterioscler Thromb Vasc Biol 19:1975–1978

    PubMed  CAS  Google Scholar 

  32. Applebaum-Bowden D, Haffner SM, Wahl PW, Hoover JJ, Warnick GR, Albers JJ, Hazzard WR (1985) Postheparin plasma triglyceride lipases. Relationships with very low density lipoprotein triglyceride and high density lipoprotein2 cholesterol. Arteriosclerosis 5:273–282

    PubMed  CAS  Google Scholar 

  33. Després JP, Ferland M, Moorjani S, Nadeau A, Tremblay A, Lupien PJ, Thériault G, Bouchard C (1989) Role of hepatic-triglyceride lipase activity in the association between intra-abdominal fat and plasma HDL cholesterol in obese women. Arteriosclerosis 9:485–492

    PubMed  Google Scholar 

  34. Jansen H, Chu G, Ehnholm C, Dallongeville J, Nicaud V, Talmud PJ (1999) The T allele of the hepatic lipase promoter variant C-480T is associated with increased fasting lipids and HDL and increased preprandial and postprandial LpCIII:B : European Atherosclerosis Research Study (EARS) II. Arterioscler Thromb Vasc Biol 19:303–308

    PubMed  CAS  Google Scholar 

  35. Zambon A, Deeb SS, Brown BG, Hokanson JE, Brunzell JD (2001) Common hepatic lipase gene promoter variant determines clinical response to intensive lipid-lowering treatment. Circulation 103:792–798

    PubMed  CAS  Google Scholar 

  36. Berns MA, de Vries JH, Katan MB (1989) Increase in body fatness as a major determinant of changes in serum total cholesterol and high density lipoprotein cholesterol in young men over a 10-year period. Am J Epidemiol 130:1109–1122

    PubMed  CAS  Google Scholar 

  37. Durstine JL, Grandjean PW, Davis PG, Ferguson MA, Alderson NL, DuBose KD (2001) Blood lipid and lipoprotein adaptations to exercise: A quantitative analysis. Sports Med 31:1033–1062

    Article  PubMed  CAS  Google Scholar 

  38. Criqui MH, Cowan LD, Tyroler HA, Bangdiwala S, Heiss G, Wallace RB, Cohn R (1987) Lipoproteins as mediators for the effects of alcohol consumption and cigarette smoking on cardiovascular mortality: results form the Lipid Research Clinics Follow-up Study. Am J Epidemiol 126:629–637

    PubMed  CAS  Google Scholar 

  39. Craig WY, Palomaki GE, Haddow JE (1989) Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. BMJ 298:784–788

    PubMed  CAS  Google Scholar 

  40. Mann JI (1997) Dietary effects on plasma LDL and HDL. Curr Opin Lipidol 8:35–38

    Article  PubMed  CAS  Google Scholar 

  41. Zhang X, Sun Z, Zheng L, Li J, Liu S, Xu C, Li J, Zhao F, Hu D, Sun Y (2007) Prevalence of dyslipidemia and associated factors among the hypertensive rural Chinese population. Arch Med Res 38:432–439

    Article  PubMed  CAS  Google Scholar 

  42. Park HS, Yun YS, Park JY, Kim YS, Choi JM (2003) Obesity, abdominal obesity, and clustering of cardiovascular risk factors in South Korea. Asia Pac J Clin Nutr 12:411–418

    PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported by the National Natural Science Foundation of China (No: 30360038).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ruixing Yin.

About this article

Cite this article

Wu, J., Yin, R., Lin, W. et al. Hepatic Lipase Gene −514C/T Polymorphism in the Guangxi Hei Yi Zhuang and Han Populations. Lipids 43, 733–740 (2008). https://doi.org/10.1007/s11745-008-3204-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11745-008-3204-3

Keywords

Navigation